Previous Article | Next Article 
Journal of Virology, March 1999, p. 2499-2508, Vol. 73, No. 3
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Functional Domains of Tat Required for Efficient
Human Immunodeficiency Virus Type 1 Reverse Transcription
Catherine
Ulich,1
Amanda
Dunne,2,
Emma
Parry,2
C. William
Hooker,2
Richard B.
Gaynor,1 and
David
Harrich2,*
Division of Hematology and Oncology,
Departments of Internal Medicine and Microbiology, University of Texas
Southwestern Medical Center, Dallas, Texas
75235-8594,1 and
HIV Research Unit,
National Centre for HIV Virology Research, Sir Albert Sakzewski
Virus Research Centre, Royal Children's Hospital, Herston,
Queensland, Australia 40292
Received 8 October 1998/Accepted 30 November 1998
Tat expression is required for efficient human immunodeficiency
virus type 1 (HIV-1) reverse transcription. In the present study, we
generated a series of 293 cell lines that contained a provirus with a
tat gene deletion (
tat). Cell lines that
contained
tat and stably transfected vectors containing
either wild-type tat or a number of tat mutants
were obtained so that the abilities of these tat genes to
stimulate HIV-1 gene expression and reverse transcription could be
compared. tat genes with mutations in the amino terminus
did not stimulate either viral gene expression or HIV-1 reverse
transcription. In contrast, tat mutants in the activation,
core, and basic domains of Tat did not stimulate HIV-1 gene expression
but markedly stimulated HIV-1 reverse transcription. No differences in
the levels of virion genomic RNA or tRNA3Lys were seen
in the HIV-1
tat viruses complemented with either mutant
or wild-type tat. Finally, overexpression of the
Tat-associated kinases CDK7 and CDK9, which are involved in Tat
activation of HIV-1 transcription, was not able to complement the
reverse transcription defects associated with the lack of a functional
tat gene. These results indicate that the mechanism by
which tat modulates HIV-1 reverse transcription is distinct
from its ability to activate HIV-1 gene expression.
*
Corresponding author. Mailing address: Sir Albert
Sakzewski Virus Research Centre, Royal Children's Hospital, Herston
Rd., Herston, Queensland, Australia 4029. Phone: 617-3253-1679. Fax: 617-3253-1401. E-mail:
d.harrich{at}mailbox.uq.edu.au.

Publication no. 94 from the Sir Albert Sakzewski Virus Research
Centre.

Present address: AIDS Pathogenesis Research Unit, Macfarlane
Burnet Centre, Fairfield, Victoria, Australia
3078.
Journal of Virology, March 1999, p. 2499-2508, Vol. 73, No. 3
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Das, A. T., Klaver, B., Harwig, A., Vink, M., Ooms, M., Centlivre, M., Berkhout, B.
(2007). Construction of a Doxycycline-Dependent Simian Immunodeficiency Virus Reveals a Nontranscriptional Function of Tat in Viral Replication. J. Virol.
81: 11159-11169
[Abstract]
[Full Text]
-
Xie, B., Calabro, V., Wainberg, M. A., Frankel, A. D.
(2004). Selection of TAR RNA-Binding Chameleon Peptides by Using a Retroviral Replication System. J. Virol.
78: 1456-1463
[Abstract]
[Full Text]
-
Apolloni, A., Hooker, C. W., Mak, J., Harrich, D.
(2003). Human Immunodeficiency Virus Type 1 Protease Regulation of Tat Activity Is Essential for Efficient Reverse Transcription and Replication. J. Virol.
77: 9912-9921
[Abstract]
[Full Text]
-
Kameoka, M., Morgan, M., Binette, M., Russell, R. S., Rong, L., Guo, X., Mouland, A., Kleiman, L., Liang, C., Wainberg, M. A.
(2002). The Tat Protein of Human Immunodeficiency Virus Type 1 (HIV-1) Can Promote Placement of tRNA Primer onto Viral RNA and Suppress Later DNA Polymerization in HIV-1 Reverse Transcription. J. Virol.
76: 3637-3645
[Abstract]
[Full Text]
-
Hooker, C. W., Lott, W. B., Harrich, D.
(2001). Inhibitors of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Target Distinct Phases of Early Reverse Transcription. J. Virol.
75: 3095-3104
[Abstract]
[Full Text]
-
Kameoka, M., Rong, L., Götte, M., Liang, C., Russell, R. S., Wainberg, M. A.
(2001). Role for Human Immunodeficiency Virus Type 1 Tat Protein in Suppression of Viral Reverse Transcriptase Activity during Late Stages of Viral Replication. J. Virol.
75: 2675-2683
[Abstract]
[Full Text]
-
Verhoef, K., Marzio, G., Hillen, W., Bujard, H., Berkhout, B.
(2001). Strict Control of Human Immunodeficiency Virus Type 1 Replication by a Genetic Switch: Tet for Tat. J. Virol.
75: 979-987
[Abstract]
[Full Text]
-
Harrich, D., Hooker, C. W., Parry, E.
(2000). The Human Immunodeficiency Virus Type 1 TAR RNA Upper Stem-Loop Plays Distinct Roles in Reverse Transcription and RNA Packaging. J. Virol.
74: 5639-5646
[Abstract]
[Full Text]
-
Jeang, K.-T., Xiao, H., Rich, E. A.
(1999). Multifaceted Activities of the HIV-1 Transactivator of Transcription, Tat. J. Biol. Chem.
274: 28837-28840
[Full Text]
-
Fujii, R., Okamoto, M., Aratani, S., Oishi, T., Ohshima, T., Taira, K., Baba, M., Fukamizu, A., Nakajima, T.
(2001). A Role of RNA Helicase A in cis-Acting Transactivation Response Element-mediated Transcriptional Regulation of Human Immunodeficiency Virus Type 1. J. Biol. Chem.
276: 5445-5451
[Abstract]
[Full Text]
-
Holloway, A. F., Occhiodoro, F., Mittler, G., Meisterernst, M., Shannon, M. F.
(2000). Functional Interaction between the HIV Transactivator Tat and the Transcriptional Coactivator PC4 in T Cells. J. Biol. Chem.
275: 21668-21677
[Abstract]
[Full Text]